Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ELMD
ELMD logo

ELMD Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Electromed Inc (ELMD) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
25.480
1 Day change
-1.58%
52 Week Range
30.730
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Electromed Inc (ELMD) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company shows strong financial performance, positive analyst sentiment, and a solid growth trajectory in its core business. Despite a slight recent price dip, the technical indicators and financials suggest a favorable long-term outlook.

Technical Analysis

The MACD histogram is positive at 0.245, indicating bullish momentum, though it is contracting. RSI is neutral at 67.557, and moving averages are converging, showing no clear trend. The stock is trading near its resistance level (R1: 25.553), suggesting limited immediate upside but potential for long-term growth.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
3
Buy
11

Positive Catalysts

  • Strong financial performance in Q2 2026, with revenue up 16.25% YoY, net income up 40.29% YoY, and EPS up 45.45% YoY.

  • Analyst upgrade with a raised price target to $38, indicating significant upside potential.

  • High gross margin of 78.42%, showcasing operational efficiency.

Neutral/Negative Catalysts

  • Lack of recent news or event-driven catalysts.

  • Slight regular market price decline of -1.24%.

Financial Performance

In Q2 2026, revenue increased to $18.897 million (+16.25% YoY), net income rose to $2.761 million (+40.29% YoY), EPS improved to $0.32 (+45.45% YoY), and gross margin expanded to 78.42% (+0.95% YoY). These metrics highlight strong growth and profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital raised the price target to $38 from $36, maintaining a Buy rating. Analysts cite strong performance in the company's core homecare business as a key driver for the positive outlook.

Wall Street analysts forecast ELMD stock price to rise
3 Analyst Rating
Wall Street analysts forecast ELMD stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 25.480
sliders
Low
36
Averages
37.33
High
38
Current: 25.480
sliders
Low
36
Averages
37.33
High
38
Roth Capital
Buy
maintain
$36 -> $38
AI Analysis
2026-02-11
Reason
Roth Capital
Price Target
$36 -> $38
AI Analysis
2026-02-11
maintain
Buy
Reason
Roth Capital raised the firm's price target on Electromed to $38 from $36 and keeps a Buy rating on the shares. The company reported results that were above expectations, largely driven by strong performance in the company's core homecare business, the analyst tells investors in a research note.
Roth Capital
Buy
maintain
$35 -> $36
2025-11-13
Reason
Roth Capital
Price Target
$35 -> $36
2025-11-13
maintain
Buy
Reason
Roth Capital raised the firm's price target on Electromed to $36 from $35 and keeps a Buy rating on the shares. The company's Q1 results were above expectations and the management reiterated its goal to drive double-digit top-line growth and expanded operating leverage, the analyst tells investors in a research note. The company's best-in-class high frequency chest wall oscillation device continues to take share in a highly underdiagnosed bronchiectasis market, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ELMD
Unlock Now

People Also Watch